He Jiahuan Helen, Bennett Wendy L, Ma Jianqiao, Oyeka Chigolum P, Kodali Lakshmi Spurthi, Srialluri Nityasree, Gisinger Teresa, Woodward Mark, Michos Erin D, Johnson Karen C, Vaidya Dhananjay
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Department of Medicine, Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
J Clin Endocrinol Metab. 2025 Jun 17. doi: 10.1210/clinem/dgaf359.
The Look AHEAD (Action in Health for Diabetes) randomized controlled trial, which compared an Intensive Lifestyle Intervention (ILI) to the Diabetes Support and Education (DSE) in people with overweight/obesity and type 2 diabetes (T2D), showed a greater decline in bone mineral density (BMD) along with greater weight loss in the ILI group. Because weight loss interventions change sex hormones and also affect BMD, understanding the role of sex hormones on these changes has implications for bone health in people with diabetes.
We assessed sex hormone mediation on BMD changes due to ILI, by sex, among postmenopausal females and older men over 4 years of follow-up.
In the Look AHEAD Sex Hormone Ancillary Study, we applied structural equation models to estimate the effects of ILI (vs. DSE) on hip, femoral neck, and whole-body BMD after 4 years of follow-up, temporally mediated by sex hormones estradiol (E2), total testosterone, bioavailable testosterone, and sex hormone binding globulin (SHBG) measured at one year after baseline (nadir of weight loss).
In females, an ILI-associated decrease in estradiol of 14% from baseline to year 1 mediated a decline in whole-body BMD (-1.15 mg/cm2, 95%CI: -2.54, -0.21). In males, an ILI-associated increase of 11% in total testosterone mediated a decline of hip BMD (-1.18 mg/cm2, 95%CI: -2.68, -0.13).
ILI-associated changes in estradiol and total testosterone resulted in whole-body and hip bone loss, providing insights in the potential role of sex hormones in bone loss accompanying weight loss in older adults with T2D who are at a higher risk of bone fractures.
“展望未来(糖尿病健康行动)”随机对照试验将强化生活方式干预(ILI)与糖尿病支持与教育(DSE)对超重/肥胖的2型糖尿病(T2D)患者进行了比较,结果显示ILI组骨矿物质密度(BMD)下降幅度更大,体重减轻也更多。由于体重减轻干预会改变性激素并影响骨密度,了解性激素在这些变化中的作用对糖尿病患者的骨骼健康具有重要意义。
我们评估了在4年随访期间,性激素对绝经后女性和老年男性因ILI导致的骨密度变化的介导作用,按性别进行分析。
在“展望未来”性激素辅助研究中,我们应用结构方程模型来估计ILI(与DSE相比)在随访4年后对髋部、股骨颈和全身骨密度的影响,这些影响由基线后一年(体重减轻最低点)测量的雌二醇(E2)、总睾酮、生物可利用睾酮和性激素结合球蛋白(SHBG)等性激素进行时间介导。
在女性中,从基线到第1年ILI导致雌二醇下降14%,介导了全身骨密度下降(-1.15mg/cm²,95%CI:-2.54,-0.21)。在男性中,ILI导致总睾酮增加11%,介导了髋部骨密度下降(-1.18mg/cm²,95%CI:-2.68,-0.13)。
ILI相关的雌二醇和总睾酮变化导致全身和髋部骨质流失,这为性激素在T2D老年骨折高风险患者体重减轻伴随的骨质流失中的潜在作用提供了见解。